ES2053508T3 - Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos. - Google Patents
Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos.Info
- Publication number
- ES2053508T3 ES2053508T3 ES87117022T ES87117022T ES2053508T3 ES 2053508 T3 ES2053508 T3 ES 2053508T3 ES 87117022 T ES87117022 T ES 87117022T ES 87117022 T ES87117022 T ES 87117022T ES 2053508 T3 ES2053508 T3 ES 2053508T3
- Authority
- ES
- Spain
- Prior art keywords
- carboxilicos
- azabiciclo
- pirrolidinyl
- eno
- hept
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cephalosporin Compounds (AREA)
Abstract
SE PRESENTA UN COMPUESTO DE FORMULA (I) EN DONDE R1 ES CARBOXI O CARBOXI PROTEGIDO, R2 ES HIDROXIALQUILO(INFERIOR) O HIDROXIALQUILO (INFERIOR) PROTEGIDO; R3 ES HIDROGENO O ALQUILO INFERIOR, R4 ES UN GRUPO HETEROCICLICO QUE PUEDE TENER SUSTITUYENTES ADECUADOS, Y R5 ES HIDROGENO O UN GRUPO IMINOPROTECTOR. SE PRESENTAN TAMBIEN SALES FARMACOLOGICAMENTE ACEPTABLES DEL COMPUESTO, PROCEDIMIENTOS PARA SU OBTENCION Y COMPOSICIONES FARMACOLOGICAS QUE LAS CONTIENEN COMO INGREDIENTE ACTIVO. LA INVENCION INCLUYE ADEMAS PRODUCTOS INTERMEDIOS DE FORMULA (II) Y PROCEDIMIENTO PARA SU OBTENCION.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868628060A GB8628060D0 (en) | 1986-11-24 | 1986-11-24 | Carboxylic acid compounds |
GB878715825A GB8715825D0 (en) | 1987-07-06 | 1987-07-06 | 3-pyrrolidinylthio-1-azabicyclo(3 2 0)hept-2-ene-2-carboxylic acid compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2053508T3 true ES2053508T3 (es) | 1994-08-01 |
Family
ID=26291578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES87117022T Expired - Lifetime ES2053508T3 (es) | 1986-11-24 | 1987-11-18 | Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos. |
Country Status (6)
Country | Link |
---|---|
US (3) | US4921852A (es) |
EP (1) | EP0272455B1 (es) |
JP (1) | JP2555648B2 (es) |
DE (1) | DE3784147T2 (es) |
ES (1) | ES2053508T3 (es) |
GR (1) | GR3007256T3 (es) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4925838A (en) * | 1988-03-18 | 1990-05-15 | Fujisawa Pharmaceutical Company, Ltd. | 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds |
US4963544A (en) * | 1988-05-23 | 1990-10-16 | Fujisawa Pharmaceutical Company, Ltd. | 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds |
AU631671B2 (en) * | 1989-08-04 | 1992-12-03 | Banyu Pharmaceutical Co., Ltd. | 2-(2-vinylpyrrolidinylthio)carbapenem derivatives |
GB8923844D0 (en) * | 1989-10-23 | 1989-12-13 | Fujisawa Pharmaceutical Co | Carbapenem compounds |
DE69013131T2 (de) * | 1989-12-29 | 1995-05-24 | Banyu Pharma Co Ltd | 2-(2-Cyclopropylpyrrolidin-4-ylthio)carbapenemderivate. |
US5374720A (en) * | 1990-03-27 | 1994-12-20 | Banyu Pharmaceutical Co., Ltd. | 2-(substituted pyrrolidinylthio)carbapenem derivatives |
TW198034B (es) * | 1990-03-27 | 1993-01-11 | Manyu Seiyaku Kk | |
US5373002A (en) * | 1990-03-27 | 1994-12-13 | Banyu Pharmaceutical Co., Ltd. | 2-(substituted pyrrolidinylthio) carbapenem derivatives |
JPH0764846B2 (ja) * | 1990-03-27 | 1995-07-12 | 萬有製薬株式会社 | 2−(置換ピロリジニルチオ)カルバペネム誘導体 |
WO1993006102A1 (en) * | 1991-09-27 | 1993-04-01 | Banyu Pharmaceutical Co., Ltd. | 2-(substituted pyrrolidinylthio) carbapenem derivative |
IL105348A0 (en) * | 1992-04-13 | 1993-08-18 | Fujisawa Pharmaceutical Co | Azabicyclo derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
KR940007029A (ko) * | 1992-09-02 | 1994-04-26 | 손정삼 | 새로운 카바페넴 유도체 및 그의 제조방법 |
AU4912393A (en) * | 1993-06-15 | 1994-12-22 | Dong Kook Pharmaceutical Co., Ltd. | 1-beta-methyl-2-thiolic carbapenem derivatives |
DE4321444A1 (de) * | 1993-06-28 | 1995-01-05 | Bernd Prof Dr Clement | Pharmazeutische Zubereitung |
WO1995023150A1 (fr) * | 1994-02-25 | 1995-08-31 | Banyu Pharmaceutical Co., Ltd. | Derive de carbapendem |
GB9507203D0 (en) * | 1995-04-07 | 1995-05-31 | Smithkline Beecham Plc | Novel compounds |
AU1682599A (en) * | 1997-12-16 | 1999-07-05 | Banyu Pharmaceutical Co., Ltd. | Carbapenem derivatives |
EP1113016A4 (en) | 1998-09-10 | 2001-12-12 | Wyeth Lederle Japan Ltd | CARBAPENEM COMPOUNDS |
KR100325375B1 (ko) * | 2000-01-31 | 2002-03-06 | 박호군 | 이미다졸린 고리가 치환된 카바페넴 유도체 |
KR100832287B1 (ko) * | 2000-11-16 | 2008-05-26 | 상꾜 가부시키가이샤 | 1-메틸카르바페넴 유도체 |
CA2584485C (en) | 2004-10-20 | 2013-12-31 | Resverlogix Corp. | Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases |
EP2314295B1 (en) | 2005-07-29 | 2015-01-28 | Resverlogix, Inc | Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
PL2118074T3 (pl) | 2007-02-01 | 2014-06-30 | Resverlogix Corp | Związki chemiczne do celów profilaktyki i leczenia chorób układu sercowo-naczyniowego |
CN101328179B (zh) * | 2007-06-15 | 2011-01-12 | 山东轩竹医药科技有限公司 | 含有氧代氮杂环的巯基吡咯烷培南衍生物 |
WO2009158404A1 (en) | 2008-06-26 | 2009-12-30 | Resverlogix Corp. | Methods of preparing quinazolinone derivatives |
NZ594332A (en) | 2009-01-08 | 2013-09-27 | Resverlogix Corp | Compounds for the prevention and treatment of cardiovascular disease |
MX337352B (es) | 2009-03-18 | 2016-02-29 | Resverlogix Corp | Nuevos agentes anti-inflamatorios. |
CN107252429B (zh) | 2009-04-22 | 2023-06-16 | 雷斯韦洛吉克斯公司 | 新抗炎剂 |
EP3616695B1 (en) | 2011-09-09 | 2024-10-23 | Merck Sharp & Dohme LLC | Ceftolozane/tazobactam for treating intrapulmonary infections |
PL2773354T3 (pl) | 2011-11-01 | 2019-12-31 | Resverlogix Corp. | Doustna formulacja o natychmiastowym uwalnianiu dla podstawowych chinazolinów |
US8809314B1 (en) | 2012-09-07 | 2014-08-19 | Cubist Pharmacueticals, Inc. | Cephalosporin compound |
US8476425B1 (en) | 2012-09-27 | 2013-07-02 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine compositions |
US9073878B2 (en) | 2012-11-21 | 2015-07-07 | Zenith Epigenetics Corp. | Cyclic amines as bromodomain inhibitors |
US9765039B2 (en) | 2012-11-21 | 2017-09-19 | Zenith Epigenetics Ltd. | Biaryl derivatives as bromodomain inhibitors |
CA2895905A1 (en) | 2012-12-21 | 2014-06-26 | Zenith Epigenetics Corp. | Novel heterocyclic compounds as bromodomain inhibitors |
US20140274991A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Ceftolozane pharmaceutical compositions |
US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
EP2893929A1 (en) | 2013-03-15 | 2015-07-15 | Cubist Pharmaceuticals, Inc. | Ceftolozane antibiotic compositions |
US10376496B2 (en) | 2013-09-09 | 2019-08-13 | Merck, Sharp & Dohme Corp. | Treating infections with ceftolozane/tazobactam in subjects having impaired renal function |
US8906898B1 (en) | 2013-09-27 | 2014-12-09 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
KR102662814B1 (ko) | 2015-03-13 | 2024-05-03 | 리스버로직스 코퍼레이션 | 보체 관련 질환을 치료하기 위한 조성물 및 치료 방법 |
WO2021165927A1 (en) * | 2020-02-21 | 2021-08-26 | Wockhardt Bio Ag | 2-cyanopyrroldines, -piperidines or -dazepines as hyperglycemic agents |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3766196A (en) * | 1971-07-26 | 1973-10-16 | Robins Co Inc A H | 3-(2-pyridyl) pyrrolidines and pyrrolines |
US4552873A (en) * | 1981-08-19 | 1985-11-12 | Sankyo Company Limited | Carbapenem compounds, and compositions containing them |
US4640915A (en) * | 1982-03-29 | 1987-02-03 | Fujisawa Pharmaceutical Co., Ltd. | 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid derivatives |
JPS5916892A (ja) * | 1982-07-19 | 1984-01-28 | Sankyo Co Ltd | カルバペネム−3−カルボン酸誘導体およびその製法 |
KR900006449B1 (ko) * | 1982-08-24 | 1990-08-31 | 상꾜 가부시끼가이샤 | 아제티디논 화합물의 제조방법 |
CA1283906C (en) * | 1983-05-09 | 1991-05-07 | Makoto Sunagawa | .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF |
JPS60202886A (ja) * | 1984-03-27 | 1985-10-14 | Sankyo Co Ltd | 1―置換カルバペネム―3―カルボン酸誘導体 |
DE3579888D1 (de) * | 1984-11-08 | 1990-10-31 | Sumitomo Pharma | Carbapenemverbindungen und deren herstellung. |
DE3821464A1 (de) * | 1988-06-25 | 1989-12-28 | Degussa | Verfahren zur herstellung substituierter organyloxysilylfunktioneller, cyclischer thioharnstoffe und diese verbindungen |
-
1987
- 1987-11-18 DE DE8787117022T patent/DE3784147T2/de not_active Expired - Fee Related
- 1987-11-18 ES ES87117022T patent/ES2053508T3/es not_active Expired - Lifetime
- 1987-11-18 EP EP87117022A patent/EP0272455B1/en not_active Expired - Lifetime
- 1987-11-24 US US07/124,603 patent/US4921852A/en not_active Expired - Fee Related
- 1987-11-24 JP JP62295902A patent/JP2555648B2/ja not_active Expired - Lifetime
-
1990
- 1990-02-06 US US07/475,975 patent/US5138064A/en not_active Expired - Fee Related
-
1992
- 1992-04-14 US US07/868,196 patent/US5420122A/en not_active Expired - Fee Related
-
1993
- 1993-03-09 GR GR920403174T patent/GR3007256T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0272455A1 (en) | 1988-06-29 |
US5138064A (en) | 1992-08-11 |
JPS63170379A (ja) | 1988-07-14 |
DE3784147D1 (en) | 1993-03-25 |
GR3007256T3 (es) | 1993-07-30 |
DE3784147T2 (de) | 1993-06-03 |
US4921852A (en) | 1990-05-01 |
JP2555648B2 (ja) | 1996-11-20 |
US5420122A (en) | 1995-05-30 |
EP0272455B1 (en) | 1993-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2053508T3 (es) | Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos. | |
ES2142798T3 (es) | Derivados de 3-amido pirazol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
ES2058527T3 (es) | Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen. | |
ES505960A0 (es) | Un procedimiento para la obtencion de un derivado acilico sustituido del compuesto acido 1,2,3,4-tetrahidro-3-isoqui- nolein-carboxilico | |
ES2067456T3 (es) | Nuevos derivados de aminoacidos, procedimientos para su preparacion y composicion farmaceutica que los comprende. | |
PT88307A (pt) | Processo de preparacao de uma composicao para a imunizacao de plantas contra microrganismos fitopatogenicos contendo derivados de 1,2,3-benzotiadiazol | |
ES2121441T3 (es) | Nuevos derivados de 3,5 -dioxo - (2h,4h) - 1,2,4 - triazina,su preparacion y aplicacion como farmaco | |
AR015103A1 (es) | Compuestos derivados de 6,6-heterobiciclicos sustituidos y composiciones que los contienen e intermediarios | |
ES2053524T3 (es) | Un procedimiento para preparar un compuesto quimico. | |
ES2150918T3 (es) | 1h-imidazo(4,5-c)quinolin-4-aminas 1-sustituidas; compuestos intermedios y composiciones farmaceuticas. | |
ES2083359T3 (es) | Piperidinas 1,4-substituidas como inhibidores de la acetilcolinesterasa y su utilizacion en el tratamiento de la enfermedad de alzheimer. | |
ES2191048T3 (es) | Derivados de oxazolidinona y compuestos farmaceuticos que los contienen. | |
ES2082805T3 (es) | Derivados de tiazol, procedimientos para su produccion y composiciones farmaceuticas que comprenden los mismos. | |
ES2045180T3 (es) | Nuevo procedimiento para la obtencion de 4-aciloxi-3-hidroxietil-azetidinonas. | |
ES2031876T3 (es) | Un procedimiento para la preparacion de 5,6-dihidro-2-(fenil sustituido)-1,2,4,-triazin-3,5(2h,4h)-dionas. | |
AR002690A1 (es) | Derivado de bencimidazol o sales del mismo, composicion farmaceutica, agente inmunosupresor y agente antiinflamatorio que lo contienen yprocedimientos para preparar dicho derivado. | |
ES2051843T3 (es) | Un proceso para la preparacion de un derivado del acido benzoilaminofenoxibutanico. | |
ES2036531T3 (es) | Un procedimiento para preparar derivados de piridazinona y composiciones insecticidas, acaricidas, nematocidas y fungicidas. | |
FI803264L (fi) | 2-hydroxialkyl-3,4,5-trihydroxipiperidiner foerfarande foer framstaellning av dem och anvaendning av dem som laekemedel | |
ES2058177T3 (es) | Nuevos derivados de alcanosulfonanilida, procedimientos para su preparacion y composiciones farmaceuticas que los contienen. | |
EA200300044A1 (ru) | Новые замещенные фталиды, способ их получения и содержащие их фармацевтические композиции | |
ES2043863T3 (es) | Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina. | |
MX168469B (es) | Procedimiento para la preparacion de derivados aminoalcoholes acilados | |
ES2032752T3 (es) | Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina. | |
CO5590934A2 (es) | Procedimiento de preparacion de derivados de equinocandina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 272455 Country of ref document: ES |